# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001372514-26-000048
Filing Date
2026-05-08
Accepted
2026-05-08 07:07:40
Documents
13
Period of Report
2026-05-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | kprx-20260508.htm iXBRL | 8-K | 26003
2 | EX-99.1 | ex991-pressreleasemarch312.htm | EX-99.1 | 91615
6 | KIORA LOGO | kprx-20260508_g1.jpg | GRAPHIC | 348944
| Complete submission text file | 0001372514-26-000048.txt |  | 1084443

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | kprx-20260508.xsd | EX-101.SCH | 1800
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | kprx-20260508_lab.xml | EX-101.LAB | 22548
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | kprx-20260508_pre.xml | EX-101.PRE | 13058
16 | EXTRACTED XBRL INSTANCE DOCUMENT | kprx-20260508_htm.xml | XML | 2809

Mailing Address 169 SAXONY RD. SUITE 212 ENCINITAS CA 92024
Business Address 169 SAXONY RD. SUITE 212 ENCINITAS CA 92024 858-224-9600
KIORA PHARMACEUTICALS INC (Filer) CIK: 0001372514 (see all company filings)

EIN.: 980443284 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36672 | Film No.: 26956021
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)